GLP-1 Drug Market growth
Personalized medicine is likely to shape the future of GLP-1 therapy. Advances in genomics and biomarker identification can enable tailored treatments that optimize effectiveness and minimize side effects.
Combination therapies and multi-receptor agonists are also expected to dominate research pipelines, offering enhanced metabolic control and improved patient outcomes. For further insights into emerging trends, consult the GLP-1 Drug Market report.
1 View